Cite

HARVARD Citation

    Arora, P. et al. (2022). The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages. Lancet infectious diseases. 22 (12), pp. 1665-1666. [Online]. 
  
Back to record